NCT02302833
- Conditions
- Locally Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Paraganglioma, +11 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Metastatic Adrenal Gland Pheochromocytoma
Explore clinical trials studying Metastatic Adrenal Gland Pheochromocytoma. Study availability and eligibility vary by location and protocol.
4 public trials
0 recruiting studies
Metastatic Adrenal Gland Pheochromocytoma trial results
NCT03008369
- Conditions
- Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, +9 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Active, Not Recruiting
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
NCT02721732
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
NCT04394858
- Conditions
- Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, +13 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States